Addition of Resolvins D1 or E1 to Collagen Membranes Mitigates Their Resorption in Diabetic Rats
Source abstract
Abstract
Uncontrolled diabetes is characterized by aberrant inflammatory reactions and increased collagenolysis. We have reported that it accelerates the degradation of implanted collagen membranes (CM), thus compromising their function in regenerative procedures. In recent years, a group of physiological anti-inflammatory agents called specialized pro-resolving lipid mediators (SPMs) have been tested as a treatment for various inflammatory conditions, either systemically or locally, via medical devices. Yet, no study has tested their effect on the fate of the biodegradable material itself. Here, we measured the in vitro release over time of 100 or 800 ng resolvin D1 (RvD1) incorporated into CM discs. In vivo, diabetes was induced in rats with streptozotocin, while buffer-injected (normoglycemic) rats served as controls. Resolvins (100 or 800 ng of RvD1 or RvE1) were added to biotin-labeled CM discs, which were implanted sub-periosteally over the calvaria of rats. Membrane thickness, density, and uniformity were determined by quantitative histology after 3 weeks. In vitro, significant amounts of RvD1 were released over 1–8 days, depending on the amount loaded. In vivo, CMs from diabetic animals were thinner, more porous, and more variable in thickness and density. The addition of RvD1 or RvE1 improved their regularity, increased their density, and reduced their invasion by the host tissue significantly. We conclude that addition of resolvins to biodegradable medical devices can protect them from excessive degradation in systemic conditions characterized by high degree of collagenolysis.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Fatty Acid Research and Health · Advanced Glycation End Products research · Protein Hydrolysis and Bioactive Peptides
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Oral Biology, The Maurice and Gabriela Goldschleger School of Dental Medicine, Tel-Aviv University, Tel Aviv-Yafo 6997801, Israel
Department of Periodontology and Implant Dentistry, The Maurice and Gabriela Goldschleger School of Dental Medicine, Tel-Aviv University, Tel Aviv-Yafo 6997801, Israel
References (73)
Show source-provided references
1. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Provisional Report of a WHO Consultation10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S ↗
2. National, Regional, and Global Trends in Fasting Plasma Glucose and Diabetes Prevalence since 1980: Systematic Analysis of Health Examination Surveys and Epidemiological Studies with 370 Country-Years and 2.7 Million Participants10.1016/S0140-6736(11)60679-X ↗
3. A Unified Pathophysiological Construct of Diabetes and Its Complications10.1016/j.tem.2017.05.005 ↗
4. Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes10.4049/jimmunol.1601543 ↗
5. Commonality in Chronic Inflammatory Diseases: Periodontitis, Diabetes, and Coronary Artery Disease10.1111/j.1600-0757.2005.00138.x ↗
6. Molecular Mechanisms of Diabetic Retinopathy: Potential Therapeutic Targets10.4103/0974-9233.154386 ↗
7. A Causal Link between Oxidative Stress and Inflammation in Cardiovascular and Renal Complications of Diabetes10.1042/CS20171459 ↗
8. Inflammation, Stress, and Diabetes10.1172/JCI25102 ↗
9. Regulatory Mechanisms of the Wnt/β-Catenin Pathway in Diabetic Cutaneous Ulcers10.3389/fphar.2018.01114 ↗
10. Effect of Diabetes on Collagen Metabolism and Hypoxia in Human Gingival Tissue: A Stereological, Histopathological, and Immunohistochemical Study10.1080/10520295.2018.1508745 ↗
11. Diosgenin Ameliorates Testicular Damage in Streptozotocin-Diabetic Rats through Attenuation of Apoptosis, Oxidative Stress, and Inflammation10.1016/j.intimp.2019.01.047 ↗
12. Antioxidative Potential of Antidiabetic Agents: A Possible Protective Mechanism against Vascular Complications in Diabetic Patients10.1002/jcp.27278 ↗
13. Greater Inflammation and Adiposity Are Associated with Lower Bone Mineral Density in Youth with Type 1 Diabetes10.1016/j.diabres.2018.07.032 ↗
14. The Role of Matrix Metalloproteinases in Diabetes Mellitus10.2174/1568026611208011159 ↗
15. Matrix Metalloproteinases in Diabetic Retinopathy: Potential Role of MMP-910.1517/13543784.2012.681043 ↗
16. Diabetes-Induced Alterations in Tissue Collagen and Carboxymethyllysine in Rat Kidneys: Association with Increased Collagen-Degrading Proteinases and Amelioration by Cu(II)-Selective Chelation10.1016/j.bbadis.2015.04.014 ↗
17. Abreu, B.J., and de Brito Vieira, W.H. (2016). Metabolic Influences on Risk for Tendon Disorders, Springer.
18. Matrix Metalloproteinases and Diabetic Vascular Complications10.1177/000331970505600208 ↗
19. Alterations of Collagen-I, MMP-1 and TIMP-1 in the Periodontal Ligament of Diabetic Rats under Mechanical Stress10.1111/j.1600-0765.2011.01359.x ↗
20. Argyropoulos, A.J., Robichaud, P., Balimunkwe, R.M., Fisher, G.J., Hammerberg, C., Yan, Y., and Quan, T. (2016). Alterations of Dermal Connective Tissue Collagen in Diabetes: Molecular Basis of Aged-Appearing Skin. PLoS ONE, 11.10.1371/journal.pone.0153806 ↗
21. Altered Fibroblast Proliferation and Apoptosis in Diabetic Gingival Wounds10.1177/0022034510362960 ↗
22. The Molecular Mechanisms of the Thrombotic Complications of Atherosclerosis10.1111/j.1365-2796.2008.01965.x ↗
23. AGEs, Rather than Hyperglycemia, Are Responsible for Microvascular Complications in Diabetes: A “Glycoxidation-Centric” Point of View10.1016/j.numecd.2013.04.004 ↗
24. A Collagen-Coated Sponge Silk Scaffold for Functional Meniscus Regeneration10.1002/term.2777 ↗
25. Clinical and Histologic Evaluations of Porcine-Derived Collagen Matrix Membrane Used for Vertical Soft Tissue Augmentation: A Case Series10.11607/prd.4097 ↗
26. Collagen Based Barrier Membranes for Periodontal Guided Bone Regeneration Applications10.1007/s10266-016-0267-0 ↗
27. A Multicenter Randomized Controlled Trial Using a Novel Collagen Mem-brane for Guided Bone Regeneration at Dehisced Single Implant Sites: Outcome at Prosthetic Delivery and at 1-year Follow-up10.1111/clr.13426 ↗
28. Recent Advances of Collagen-Based Biomaterials: Multi-Hierarchical Structure, Modification and Biomedical Applications10.1016/j.msec.2019.02.070 ↗
29. Collagen Sponges for Bone Regeneration with RhBMP-210.1016/j.addr.2003.08.010 ↗
30. Bone Regeneration of Peri-Implant Defects Using a Collagen Membrane as a Carrier for Recombinant Human Bone Morpho-genetic Protein-210.1155/2018/5437361 ↗
31. Effect of Targeted Delivery of Bone Morphogenetic Protein-2 on Bone Formation in Type 1 Diabetes10.11607/jomi.3957 ↗
32. Collagen Peptide Modified Carboxymethyl Cellulose as Both Antioxidant Drug and Carrier for Drug Delivery against Retinal Ischaemia/Reperfusion Injury10.1111/jcmm.13768 ↗
33. Evaluation of Cilia Function in Rat Trachea Recon-structed Using Collagen Sponge Scaffold Seeded with Adipose Tissue-Derived Stem Cells10.1002/ar.24104 ↗
34. Mitigation of Diabetes-Related Complications in Implanted Collagen and Elastin Scaffolds Using Matrix-Binding Polyphenol10.1016/j.biomaterials.2012.09.081 ↗
35. Socarrás, T.O., Vasconcelos, A.C., Campos, P.P., Pereira, N.B., Souza, J.P.C., and Andrade, S.P. (2014). Foreign Body Response to Subcutaneous Implants in Diabetic Rats. PLoS ONE, 9.10.1371/journal.pone.0110945 ↗
36. Diabetes Alters Inflammation, Angiogenesis, and Fibrogenesis in Intraperitoneal Implants in Rats10.1016/j.mvr.2014.02.011 ↗
37. Biomaterials for Tissue Engineering10.1007/s10439-013-0859-6 ↗
38. The Concept of Induced Membrane for Reconstruction of Long Bone Defects10.1016/j.ocl.2009.07.011 ↗
39. Dimitriou, R., Jones, E., McGonagle, D., and Giannoudis, P.V. (2011). Bone Regeneration: Current Concepts and Future Directions. BMC Med., 9.10.1186/1741-7015-9-66 ↗
40. Biomaterial Selection for Bone Augmentation in Implant Dentistry: A Systematic Review10.4103/japtr.JAPTR_327_18 ↗
41. Guided Bone Regeneration with Collagen Membranes and Particulate Graft Materials: A Systematic Review and Meta-Analysis10.11607/jomi.5461 ↗
42. Collagen Membrane Resorption in Dogs: A Comparative Study10.1097/00008505-200101000-00016 ↗
43. Accelerated Degradation of Collagen Membranes in Type 1 Diabetic Rats Is Associated with Increased Expression and Production of Several Inflammatory Molecules10.1002/JPER.19-0503 ↗
44. Accelerated Degradation of Collagen Membranes in Diabetic Rats Is Associated with Increased Infiltration of Macrophages and Blood Vessels10.1007/s00784-015-1635-9 ↗
45. Opposing Effects of Diabetes and Tetracycline on the Degradation of Collagen Membranes in Rats10.1902/jop.2012.120188 ↗
46. Hyaluronic Acid Slows down Collagen Membrane Degradation in Uncontrolled Diabetic Rats10.1111/jre.12665 ↗
47. Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing10.1084/jem.192.8.1197 ↗
48. Resolvins: A Family of Bioactive Products of Omega-3 Fatty Acid Transformation Circuits Initiated by Aspirin Treatment that Counter Proinflammation Signals10.1084/jem.20020760 ↗
49. New Endogenous Anti-Inflammatory and Proresolving Lipid Mediators: Implications for Rheumatic Diseases10.1038/ncprheum0616 ↗
50. Pro-Resolving Lipid Mediators Are Leads for Resolution Physiology10.1038/nature13479 ↗
51. Specific Lipid Mediator Signatures of Human Phagocytes: Microparticles Stimulate Macrophage Efferocytosis and pro-Resolving Mediators10.1182/blood-2012-04-423525 ↗
52. Proresolving Lipid Mediators and Diabetic Wound Healing10.1097/MED.0b013e3283514e00 ↗
53. Resolvin E1, an Endogenous Lipid Mediator Derived from Omega-3 Eicosapentaenoic Acid, Protects against 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis10.1073/pnas.0409271102 ↗
54. Specialized Proresolving Mediator Targets for RvE1 and RvD1 in Peripheral Blood and Mechanisms of Resolution10.1042/BJ20110327 ↗
55. Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes10.1615/CritRevImmunol.2018026750 ↗
56. Pro-Resolution Potency of Resolvins D1, D2 and E1 on Neutrophil Migration and in Dermal Wound Healing10.1142/S1793984417500027 ↗
57. Perivascular Delivery of Resolvin D1 Inhibits Neointimal Hyperplasia in a Rabbit Vein Graft Model10.1016/j.jvs.2018.05.206 ↗
58. Kim, A.S., Werlin, E.C., Kagaya, H., Chen, M., Wu, B., Mottola, G., Jan, M., and Conte, M.S. (2022). 17R/S-Benzo-RvD1, a Synthetic Resolvin D1 Analogue, Attenuates Neointimal Hyperplasia in a Rat Model of Acute Vascular Injury. PLoS ONE, 17.10.1371/journal.pone.0264217 ↗
59. Resolvin E1 Accelerates Pulp Repair by Regulating Inflammation and Stimulating Dentin Regeneration in Dental Pulp Stem Cells10.1186/s13287-021-02141-y ↗
60. RvE1 Protects from Local Inflammation and Osteoclastmediated Bone Destruction in Periodontitis10.1096/fj.05-4724fje ↗
61. Development of an Immunomodulatory Biomaterial: Using Resolvin D1 to Modulate Inflammation10.1016/j.biomaterials.2015.02.120 ↗
62. Unidirectional and Sustained Delivery of the Proresolving Lipid Mediator Resolvin D1 from a Biodegradable Thin Film Device10.1002/jbm.a.35861 ↗
63. Inflammatory Molecules and Pathways in the Pathogenesis of Diabetic Nephropathy10.1038/nrneph.2011.51 ↗
64. Effect of Hyperglycemia on Apoptosis of Notochordal Cells and Intervertebral Disc Degeneration in Diabetic Rats10.3171/2009.6.SPINE09198 ↗
65. A Novel Chemically Modified Curcumin “Normalizes” Wound-Healing in Rats with Experimentally Induced Type I Diabetes: Initial Studies10.1155/2016/5782904 ↗
66. Aspirin-Triggered Resolvin D1-Modified Materials Promote the Accumulation of pro-Regenerative Immune Cell Subsets and Enhance Vascular Remodeling10.1016/j.actbio.2017.02.020 ↗
67. Resolvin D1 Reduces Inflammation in Co-Cultures of Primary Human Macrophages and Adipocytes by Triggering Macrophages10.1016/j.plefa.2021.102363 ↗
68. Perivascular Delivery of Resolvin D1 Inhibits Neointimal Hyperplasia in a Rat Model of Arterial Injury10.1016/j.jvs.2016.01.030 ↗
69. Resolution Phase of Inflammation: Novel Endogenous Anti-Inflammatory and Proresolving Lipid Mediators and Pathways10.1146/annurev.immunol.25.022106.141647 ↗
70. Resolvin D1 Ameliorates Nicotinamide-Streptozotocin-Induced Type 2 Diabetes Mellitus by Its Anti-Inflammatory Action and Modulating PI3K/Akt/MTOR Pathway in the Brain10.1016/j.arcmed.2020.05.002 ↗
71. D-series Resolvin Attenuates Vascular Smooth Muscle Cell Activation and Neointimal Hyperplasia Following Vascular Injury10.1096/fj.12-225615 ↗
72. Chitosan Porous 3D Scaffolds Embedded with Resolvin D1 to Improve in Vivo Bone Healing10.1002/jbm.a.36370 ↗
73. The Effect of Resolvin D1 on Bone Regeneration in a Rat Calvarial Defect Model10.1002/term.3345 ↗